Navigation Links
Roche Receives FDA Approval for Acute Hepatitis B Test
Date:10/31/2011

INDIANAPOLIS, Oct. 31, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas® 6000 analyzer series for mid-volume laboratories. The test represents the final component of the acute panel within the hepatitis test menu for the cobas 6000 series.

The Anti-HBc IgM assay is used for the in-vitro qualitative determination of IgM antibodies to hepatitis B core antigen (anti-HBc IgM) in human serum or plasma.  The presence of anti-HBc IgM, in conjunction with other laboratory results and clinical information, is indicative of an acute or recent hepatitis B virus (HBV) infection.* The assay is intended for use with Roche's electrochemiluminescence (ECL) technology, a highly sensitive light detection system that provides excellent low-end sensitivity and broad dynamic measuring ranges.

With this approval, Roche now offers a full selection of hepatitis tests in its immunoassay portfolio:  HBsAg, HBsAg Confirmatory, Anti-HBs, Anti-HCV, Anti-HAV, Anti-HAV IgM, Anti-HBc IgM (approved for cobas e 601 analyzer) and Anti-HBc (approved for MODULAR ANALYTICS E170 analyzer). The combination of full hepatitis menu with the lowest assay duration on the market, the broadest integrated menu and ECL technology allows the Roche total solution to inspire confidence in the laboratory environment. The Anti-HBc IgM assay is also pending FDA approval for use on Roche's cobas e 411 and MODULAR ANALYTICS E170 analyzers. Roche's current analyzer portfolio offers labs short assay duration (9 to 27 minutes) and the broadest test menu available on an integrated platform.  

About RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combine
'/>"/>

SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... Officer, will present live at VirtualInvestorConferences.com on March ... join us for this Company update," said Mr. ... commercial launch of the exVive3D Liver, Bioprinted Human ...
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, ... its lead product for the orphan condition acromegaly, today ... financing round. Participants in the financing included new investors ... blue chip public investment fund, as well as existing ... Abingworth and ARCH Venture Partners. Chiasma ...
(Date:2/26/2015)... -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), ... and t:flex™ Insulin Pumps, today announced the pricing of ... common stock at a price to the public of ... this offering are expected to be $56.3 million, after ... expenses payable by Tandem. All of the shares of ...
Breaking Medicine Technology:Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... announces that a new market research report is available ... Blood Banking Market http://www.reportlinker.com/p0365340/The-2011-Japanese-Blood-Banking-Market.html ... the Japanese blood banking market, including: Major ... well as key economic, regulatory, demographic, social and technological ...
... announces that a new market research report is ... of the Western European Peripheral Interventional Devices Market ... The objective of this research service is ... European peripheral interventional devices market. This service provides ...
Cached Medicine Technology:Reportlinker Adds The 2011 Japanese Blood Banking Market 2Reportlinker Adds Overview of the Western European Peripheral Interventional Devices Market 2
(Date:2/28/2015)... The World Scout League Commission (WSLC), ... potential EMTs and firefighters, recently announced its decision to ... to raise charitable donations for age-related research. The five-kilometer ... be held on March 29, 2015; registration will start ... 3:30 p.m. , To participate in the race, ...
(Date:2/27/2015)... Hispanics develop alcoholic liver disease (ALD), a ... years earlier than Whites/Caucasians or African Americans, according to ... While previous research indicated that Hispanics tend to have ... -- published online in the journal Alcoholism: Clinical and ... to pinpoint racial and ethnic disparities in the ages ...
(Date:2/27/2015)... Beverly Hills, CA (PRWEB) February 27, 2015 ... Health found a correlation between men who cycle on ... for your overall health, the study suggests that the more ... he is to develop prostate cancer, leading to an increased ... important because it allows physicians to look more closely at ...
(Date:2/27/2015)... 2015 Today, February 27th, is "Shine A ... along with LXR Organics and Living Fuel, ... to raise awareness and promote prevention, rescue and restoration for ... the END IT Coalition, slavery is the 2nd largest global ... in 167 countries around the world. Slavery includes bonded labor, ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Altec ... LLP (BPW) has been chosen as their doc-link for ... GP, CRM and other complimentary solutions for their customers ... working with credit unions. Altec and BPW have worked ... doc-link’s integration to Dynamics GP. , “We are so ...
Breaking Medicine News(10 mins):Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 3
... 2008, TORONTOWhen men present in emergency departments with pneumonia, ... have a greater risk of dying over the next ... according to research from the University of Pittsburgh that ... International Conference in Toronto on Tuesday, May 20. Even ...
... recurring disease, researchers say , , SUNDAY, May 18 ... cancer appears safe and may be effective, according to ... could give hope to men with metastatic prostate cancer ... The vaccine was developed to enable a patient,s immune ...
... children need food, water, shelter, BEIJING, May ... is rushing today to pack and ship emergency ... earthquake which devastated several,counties in central Sichuan. The ... being called the most powerful earthquake to hit ...
... PHILADELPHIA - A poster session presented today by The ... the Oncology Nurses Society 33rd Annual Congress, found that ... lead to a decrease in the incidence of lymphedema, ... life in breast cancer patients. , The literature ...
... In the aftermath of central China,s,earthquake, up ... their lives, and,over 150,000 were injured. An estimated ... who have lost their homes. With great sorrow ... Hai donated an,additional US$30,000, for a total of ...
... hormone readings, study says , , FRIDAY, May 16 (HealthDay News) ... a hormone secreted by the parathyroid glands may increase the ... report. , The Dutch study, published in the May ... speculation by researchers that vitamin D, depression and other psychiatric ...
Cached Medicine News:Health News:Gender disparity in community-acquired pneumonia 2Health News:Prostate Cancer Vaccine Looks Promising in Early Trial 2Health News:Prostate Cancer Vaccine Looks Promising in Early Trial 3Health News:Updated: UNICEF Rushing Emergency Relief to Children in Sichuan 2Health News:Updated: UNICEF Rushing Emergency Relief to Children in Sichuan 3Health News:M. D. Anderson nurse addresses lymphedema in breast cancer patients and survivors 2Health News:M. D. Anderson nurse addresses lymphedema in breast cancer patients and survivors 3Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2Health News:Low Vitamin D Tied to Depression in Older Adults 2
... Shandon Hyperclean 20 fume containment system ... with a swing-down front panel hinges ... the front opening. The sides ... acrylic which is impervious to most ...
... test delivers excellent sensitivity and specificity for ... simple, easy-to-use test that provides results in ... and ease-of-use enables you to deliver improved ... diagnosing and treating patients with pharyngitis. The ...
... The FLU OIA A/B test combines performance equivalence ... of Influenza A or B with a simple, ... minutes. The test has all the same procedural ... test will enable you decrease costs for unnecessary ...
... The Acceava Mononucleosis test provides superior ... with a simple procedure that provides ... evaluations with competitive products will convince ... attributes enable you to deliver improved ...
Medicine Products: